Korean Journal of Family Medicine

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis

Hee-Won Suh, Hyun-Ok Kim, Young Sik Kim, Sung Sunwoo, Jung Ah Lee, Hye-Ree Lee, Byungsung Kim, Dae Hyun Kim, Youn Seon Choi, Yoo Seock Cheong, Keunsang Yum, Yun Jun Yang, Byung-Yeon Yu, Chung Hwan Cho, Sat-Byul Park, Dong Hyeok Shin,

Korean J Fam Med. 2012;33(6):346-355. Published online November 27, 2012
DOI: https://doi.org/10.4082/kjfm.2012.33.6.346

The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis

Korean Journal of Family Medicine. 2012;33(6):346

Link1

Improved dosage form of the combined alendronate and calcitriol (Maxmarvil®) on the absorption of alendronate in Korean postmenopausal women

Yoon-Sok Chung, Yong Jun Choi, So Hee Kim

Archives of Pharmacal Research. 2013;36(8):966-972

Link1

Link2 Link3

Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

Y. Rhee, M. Kang, Y. Min, D. Byun, Y. Chung, C. Ahn, K. Baek, J. Mok, D. Kim*, D. Kim**, H. Kim, Y. Kim, S. Myoung, D. Kim***, S.-K. Lim

Osteoporosis International. 2006;17(12):1801-1807

Link1

Link2 Link3

Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis

T. Lin, C. Wang, X.-Z. Cai, X. Zhao, M.-M. Shi, Z.-M. Ying, F.-Z. Yuan, C. Guo, S.-G. Yan

International Journal of Clinical Practice. 2012;66(4):399-408

Link1 Link2

Comparison of Calcitriol Treatment with Etidronate–Calcitriol and Calcitonin–Calcitriol Combinations in Turkish Women with Postmenopausal Osteoporosis: A Prospective Study

A. Gürlek, M. Bayraktar, O. Gedik

Calcified Tissue International. 1997;61(1):39-43

Link1

Link2 Link3

Alendronate improves QOL of postmenopausal women with osteoporosis

Hisaya Kawate

Clinical Interventions in Aging. 2010;123

Link1

A Comparison of Continuous Alendronate, Cyclical Alendronate and Cyclical Etidronate with Calcitriol in the Treatment of Postmenopausal Vertebral Osteoporosis: A Randomized Controlled Trial

O. Sahota, I. Fowler, P. J. Blackwell, N. Lawson, S. A. Cawte, P. San, T. Masud, D. J. Hosking

Osteoporosis International. 2000;11(11):959-966

Link1

Link2 Link3

Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis

Jun-Il Yoo, Yong-Chan Ha, Ye-Yeon Won, Kyu-Hyun Yang, Sang-Bum Kim, Ju-Hyung Yoo, Dong-Soo Kim

Journal of Bone Metabolism. 2017;24(2):91

Link1 Link2 Link3

Risk of Calcium Oxalate Nephrolithiasis after Calcium or Combined Calcium and Calcitriol Supplementation in Postmenopausal Women

S. Domrongkitchaiporn, B. Ongphiphadhanakul, W. Stitchantrakul, N. Piaseu, S. Chansirikarn, G. Puavilai, R. Rajatanavin

Osteoporosis International. 2000;11(6):486-492

Link1

Link2 Link3

Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent

B.L. Clarke

Yearbook of Medicine. 2010;2010:491-493

Link1 Link2